Mesa Laboratories, Inc. (MLAB) Revenue, Earnings & Financial Statements
$135.84NASDAQ: MLABMarket Cap $763.49M
Data as of Nov 16, 2026 (intraday, delayed) · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)
Mesa Laboratories, Inc. most recently reported annual revenue of $249.0M, net profit of $7.0M. Revenue grew at an average annual rate of 13.2% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Mesa Laboratories, Inc.: Revenue rose from $94.0M in 2017 to $249.0M in 2026, a change of +164.9% over 9 years; net profit was positive in 7 of 10 reported years; operating margin moved from 17.4% to 7.4%, a shift of -10.0 percentage points; the most recent year shows net profit of $7.0M.
Income Statement — 10 Years (USD millions)
Metric
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Revenue
$94.0M
$96.0M
$103.0M
$118.0M
$134.0M
$184.0M
$219.0M
$216.0M
$241.0M
$249.0M
Operating Expenses
$77.0M
$94.0M
$93.0M
$110.0M
$122.0M
$180.0M
$216.0M
$488.0M
$225.0M
$231.0M
Operating Profit
$16.0M
$2.0M
$10.0M
$8.0M
$12.0M
$5.0M
$3.0M
−$272.0M
$16.0M
$19.0M
Operating Margin
17.4%
2.3%
9.5%
6.7%
9.2%
2.5%
1.5%
-125.8%
6.8%
7.4%
Other Income
−$2.0M
−$2.0M
−$1.0M
−$4.0M
−$10.0M
−$1.0M
−$4.0M
−$4.0M
−$10.0M
−$6.0M
Interest
$0
$2.0M
$0
$6.0M
$8.0M
$4.0M
$5.0M
$6.0M
$12.0M
$11.0M
Depreciation
$9.0M
$9.0M
$9.0M
$13.0M
$18.0M
$25.0M
$33.0M
$32.0M
$25.0M
$23.0M
Profit Before Tax
$14.0M
$0
$9.0M
$4.0M
$2.0M
$4.0M
$0
−$276.0M
$6.0M
$12.0M
Tax rate (%)
21.8%
1084.0%
13.2%
54.0%
-42.2%
47.6%
339.1%
7.8%
133.1%
44.1%
Net Profit
$11.0M
−$3.0M
$7.0M
$2.0M
$3.0M
$2.0M
$1.0M
−$254.0M
−$2.0M
$7.0M
EPS
$2.91
−$0.79
$1.86
$0.31
$0.64
$0.35
$0.17
−$47.20
−$0.36
$1.21
Quarterly Results — Last 12 Quarters (USD millions)
8 duplicate period labels in the source data were collapsed.
Metric
Dec '23
Mar '24
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Sep '26
Revenue
$53.0M
$59.0M
$58.0M
$58.0M
$63.0M
$62.0M
$60.0M
$61.0M
$65.0M
$64.0M
$60.0M
$62.0M
Operating Expenses
$54.0M
$330.0M
$53.0M
$54.0M
$57.0M
$61.0M
$56.0M
$56.0M
$57.0M
$61.0M
$53.0M
$54.0M
Operating Profit
$0
−$271.0M
$6.0M
$4.0M
$6.0M
$1.0M
$3.0M
$5.0M
$8.0M
$3.0M
$7.0M
$8.0M
Operating Margin
-0.1%
-460.6%
9.6%
6.1%
9.2%
2.4%
5.2%
7.8%
12.3%
4.3%
11.7%
13.5%
Interest
$2.0M
$2.0M
$3.0M
$3.0M
$3.0M
$3.0M
$2.0M
$3.0M
$3.0M
$3.0M
$2.0M
$2.0M
Profit Before Tax
$2.0M
−$275.0M
$4.0M
$4.0M
−$2.0M
$0
$7.0M
$2.0M
$5.0M
−$2.0M
$4.0M
$6.0M
Tax rate (%)
-8.7%
7.5%
13.2%
10.1%
24.4%
1643.2%
32.4%
-23.9%
21.0%
-159.6%
35.0%
28.1%
Net Profit
$2.0M
−$255.0M
$3.0M
$3.0M
−$2.0M
−$7.0M
$5.0M
$2.0M
$4.0M
−$4.0M
$3.0M
$4.0M
EPS
$0.39
−$47.20
$0.62
$0.63
−$0.31
−$1.31
$0.85
$0.45
$0.65
−$0.75
$0.49
$0.75
Over the 10 years reported for Mesa Laboratories, Inc., borrowings increased from $55.0M in 2017 to $169.0M in 2026, cash stood at $27.0M in the latest year, shareholders' equity was $375.0M, current assets covered current liabilities 1.71 times.
Balance Sheet — 10 Years (USD millions)
Metric
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
$172.0M
$164.0M
$157.0M
$420.0M
$601.0M
$707.0M
$662.0M
$447.0M
$433.0M
$428.0M
Current Assets
$36.0M
$32.0M
$34.0M
$123.0M
$304.0M
$124.0M
$119.0M
$109.0M
$103.0M
$106.0M
Cash
$6.0M
$5.0M
$10.0M
$81.0M
$264.0M
$49.0M
$33.0M
$28.0M
$27.0M
$27.0M
Inventory
$14.0M
$9.0M
$7.0M
$14.0M
$11.0M
$25.0M
$35.0M
$33.0M
$25.0M
$26.0M
Receivables
$14.0M
$14.0M
$13.0M
$21.0M
$24.0M
$41.0M
$43.0M
$39.0M
$42.0M
$44.0M
Fixed Assets
$26.0M
$24.0M
$22.0M
$22.0M
$22.0M
$29.0M
$28.0M
$41.0M
$32.0M
$48.0M
Capital Work in Progress
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
Investments
−$113.0M
−$109.0M
$0
−$273.0M
$0
$0
$0
$0
$0
$0
Other Assets
$72.0M
$66.0M
$66.0M
$142.0M
$161.0M
$291.0M
$286.0M
$180.0M
$182.0M
$187.0M
Total Liabilities
$74.0M
$65.0M
$45.0M
$200.0M
$195.0M
$314.0M
$268.0M
$301.0M
$274.0M
$242.0M
Current Liabilities
$17.0M
$17.0M
$24.0M
$26.0M
$33.0M
$48.0M
$43.0M
$44.0M
$164.0M
$62.0M
Borrowings
$55.0M
$46.0M
$23.0M
$141.0M
$147.0M
$221.0M
$186.0M
$231.0M
$181.0M
$169.0M
Other Liabilities
$19.0M
$18.0M
$23.0M
$59.0M
$49.0M
$92.0M
$82.0M
$70.0M
$92.0M
$73.0M
Equity
$26.0M
$31.0M
$40.0M
$158.0M
$318.0M
$313.0M
$332.0M
$344.0M
$359.0M
$375.0M
Reserves
$98.0M
$99.0M
$111.0M
$220.0M
$406.0M
$394.0M
$393.0M
$145.0M
$160.0M
$186.0M
For Mesa Laboratories, Inc., operating cash flow was positive in 10 of 10 reported years; free cash flow in the latest year was $40.0M; free cash flow was positive in 9 of 10 years; financing activities used $12.0M in the latest year, which covers debt repayment, dividends and buybacks.
Cash Flow Statement — 10 Years (USD millions)
Metric
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Operating Cash Flow
$8.0M
$25.0M
$31.0M
$27.0M
$37.0M
$39.0M
$28.0M
$44.0M
$47.0M
$43.0M
Investing Cash Flow
−$37.0M
−$20.0M
−$5.0M
−$187.0M
−$4.0M
−$310.0M
−$14.0M
−$84.0M
−$9.0M
−$6.0M
Financing Cash Flow
$0
$3.0M
−$6.0M
−$5.0M
$3.0M
$7.0M
$6.0M
−$1.0M
$1.0M
−$12.0M
Net Cash Flow
$0
$0
$5.0M
$71.0M
$182.0M
−$215.0M
−$16.0M
−$5.0M
−$1.0M
$0
Free Cash Flow
−$4.0M
$22.0M
$29.0M
$25.0M
$35.0M
$35.0M
$23.0M
$42.0M
$42.0M
$40.0M
Valuation & Return Ratios
Metric
Value
PEG Ratio
0.18
EV / EBITDA
19.04
FCF Yield
6.42%
Quick Ratio
1.39
Interest Coverage
2.58
Return 1Y
85.76%
Return 3Y
54.64%
Return 5Y
-55.00%
Mesa Laboratories, Inc. (MLAB) financials — frequently asked questions
What is Mesa Laboratories, Inc.'s annual revenue?
Mesa Laboratories, Inc. (MLAB) reported annual revenue of $249.0M in its most recent fiscal year.
What is Mesa Laboratories, Inc.'s net profit?
Mesa Laboratories, Inc. (MLAB) reported net profit of $7.0M in its most recent fiscal year.
What is MLAB EV/EBITDA?
Mesa Laboratories, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is 19.04.
Revenue and earnings of other Medical - Specialties stocks